Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.45% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.1% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4801
Pitney Bowes
PBI
$2.37B
| $307K | ﹤0.01% |
+86,664
| New | +$300K |
|
4802
Sight Sciences
SGHT
$286M
| $306K | ﹤0.01% |
36,952
-299,960
| -89% | -$2.7M |
|
4803
CALL
Wayfair
W
$11.2B
| $306K | ﹤0.01% |
4,700
-291,400
| -98% | -$12.3M |
|
4804
Marcus & Millichap
MMI
$1.16B
| $305K | ﹤0.01% |
+9,692
| New | +$300K |
|
4805
CALL
Intercontinental Exchange
ICE
$85.6B
| $305K | ﹤0.01% |
2,700
| – | – |
|
4806
ProShares UltraPro Dow 30
UDOW
$841M
| $305K | ﹤0.01% |
+10,232
| New | +$290K |
|
|
VBNK
4807
VersaBank
VBNK
$623M
| $305K | ﹤0.01% |
40,727
+18,426
| +83% | +$133K |
|
|
NOVA
4808
DELISTED
Sunnova Energy
NOVA
| $305K | ﹤0.01% |
16,631
-4,245
| -20% | -$72K |
|
4809
PUT
Pliant Therapeutics
PLRX
$64.4M
| $304K | ﹤0.01% |
+16,800
| New | +$398K |
|
4810
CALL
Chewy
CHWY
$9.25B
| $304K | ﹤0.01% |
+7,700
| New | +$268K |
|
4811
iShares Global REIT ETF
REET
$5.09B
| $302K | ﹤0.01% |
+13,147
| New | +$300K |
|
4812
LifeVantage
LFVN
$81.1M
| $302K | ﹤0.01% |
69,400
+2,138
| +3% | +$8.83K |
|
4813
PUT
Axsome Therapeutics
AXSM
$11.2B
| $302K | ﹤0.01% |
+4,200
| New | +$310K |
|
4814
PUT
TriplePoint Venture Growth BDC
TPVG
$184M
| $302K | ﹤0.01% |
+25,600
| New | +$289K |
|
|
CANO
4815
DELISTED
Cano Health, Inc.
CANO
| $301K | ﹤0.01% |
2,168
-27,918
| -93% | -$3.58M |
|
4816
BigBear.ai
BBAI
$1.34B
| $300K | ﹤0.01% |
127,583
+69,747
| +121% | +$177K |
|
4817
Lesaka Technologies
LSAK
$396M
| $300K | ﹤0.01% |
+78,633
| New | +$302K |
|
|
NGM
4818
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $299K | ﹤0.01% |
115,604
-547,362
| -83% | -$1.95M |
|
4819
Schwab US Broad Market ETF
SCHB
$43.2B
| $299K | ﹤0.01% |
+17,361
| New | +$283K |
|
4820
iShares MSCI Israel ETF
EIS
$889M
| $299K | ﹤0.01% |
+5,582
| New | +$302K |
|
4821
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.83B
| $299K | ﹤0.01% |
+7,304
| New | +$300K |
|
|
ANSS
4822
CALL
DELISTED
Ansys
ANSS
| $297K | ﹤0.01% |
+900
| New | +$285K |
|
4823
Genmab
GMAB
$17.7B
| $296K | ﹤0.01% |
7,781
-298,641
| -97% | -$11.9M |
|
4824
CALL
AC Immune
ACIU
$223M
| $296K | ﹤0.01% |
+100,000
| New | +$218K |
|
4825
Karooooo
KARO
$1.98B
| $295K | ﹤0.01% |
12,657
+2,156
| +21% | +$48.8K |
|
Similar funds
Millennium Management's Q2 2023 Portfolio in Review
As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
- Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.